The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Melnikov A.Yu.

Research and Clinical Center of Otorhinolaryngology by Federal Biomedical Agency, Moscow, Russia

Acute insomnia: natural course and correction modalities

Authors:

Melnikov A.Yu.

More about the authors

Read: 7590 times


To cite this article:

Melnikov AYu. Acute insomnia: natural course and correction modalities. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4‑2):28‑35. (In Russ.)
https://doi.org/10.17116/jnevro201911904228

Recommended articles:
Obstructive sleep apnea and epilepsy como­rbidity: possible complications and treatment options. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5-2):29-33
Pharmacological and non-pharmacological treatment for narcolepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5-2):55-62
Bidi­rectional links between sleep deprivation and neurodegenerative diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5-2):74-80

References:

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.
  2. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
  3. Classification of sleep disorders. International classification of sleep disorders, Russian variant (In Russ.) http://rossleep.ru/metodicheskie-rekomendatsii/klassifikatsiya-narusheniy-sna/
  4. Spielman AJ, Saskin P, Thorpy MJ. Treatment of Chronic Insomnia by Restriction of Time in Bed. Sleep. 1987;10(1):45-56. https://doi.org/10.1093/sleep/10.1.45
  5. Ellis J, Perlis M, Neale L, Espie C, Bastien C. The natural history of insomnia: Focus on prevalence and incidence of acute insomnia. Journal of Psychiatric Research. 2012;46(10):1278-1285. https://doi.org/10.1016/j.jpsychires.2012.07.001
  6. The Gallup Organization. The Gallup study of sleeping habits. Princeton, NJ: The Gallup Organization; 1979.
  7. Healy ES, Kales A, Monroe LJ, Bixler EO, Chamberlin K, Soldatos CR. Onset of insomnia: Role of life-stress events. Psychosomatic Medicine. 1981;43:439-451. https://doi.org/10.1097/00006842-198110000-00007
  8. Ellis JG, Gehrman P, Espie CA, Riemann D, Perlis ML. Acute insomnia: Current conceptualizations and future directions. Sleep Medicine Reviews. 2012;16(1):5-14. https://doi.org/10.1016/j.smrv.2011.02.002
  9. Ellis JG, Perlis ML, Bastien CH, Gardani M, Espie CA. The Natural History of Insomnia: Acute Insomnia and First-onset Depression. Sleep. 2014;37(1):97-106. https://doi.org/10.5665/sleep.3316
  10. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gonçalves M, Hertenstein E, Jansson-Fröjmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weeß HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
  11. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2017;13(02):307-349. https://doi.org/10.5664/jcsm.6470
  12. Sellers EM, Hoornweg K, Busto UE, Romach MK. Risk of drug dependence and abuse posed by barbiturate-containing analgesics. Can J Clin Pharmacol. 1999;6:18-25.
  13. Livanov GA, Lodyagin AN, Kovalenko AL, Batotsyrenov BV, Glushkov SI, Prokopovich GA, Antonova AM, Shestova GV, Ippolitova AA. Peculiarities of barbituric acid derivatives acute poisoning clinical picture in patients of elderly and senile age and their therapy. Adv Gerontol. 2018;31(2):239-245. (In Russ.)
  14. Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews. 2018;70(2):197-245. https://doi.org/10.1124/pr.117.014381
  15. Manconi M, Ferri R, Miano S, Maestri M, Bottasini V, Zucconi M, Ferini-Strambi L. Sleep architecture in insomniacs with severe benzodiazepine abuse. Clinical Neurophysiology. 2017;128(6):875-881. https://doi.org/10.1016/j.clinph.2017.03.009
  16. Dockhorn RJ, Dockhorn DW. Zolpidem in the Treatment of Short-Term Insomnia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Clinical Neuropharmacology. 1996;19(4):333-340. https://doi.org/10.1097/00002826-199619040-00006
  17. Gunja N. In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving. Journal of Medical Toxicology. 2013;9(2):163-171. https://doi.org/10.1007/s13181-013-0294-y
  18. Dolder CR, Nelson MH. Hypnosedative-Induced Complex Behaviours. CNS Drugs. 2008;22(12):1021-1036. https://doi.org/10.2165/0023210-200822120-00005
  19. Bon OL. Low-dose Trazodone Effective in Insomnia. Pharmacopsychiatry. 2005;38(5):226-226. https://doi.org/10.1055/s-2005-873160
  20. Karsten J, Hagenauw LA, Kamphuis J, Lancel M. Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial. Journal of Psychopharmacology. 2017;31(3):327-337. https://doi.org/10.1177/0269881116681399
  21. Kamphuis J, Taxis K, Schuiling-Veninga CCM, Bruggeman R, Lancel M. Off-Label Prescriptions of Low-Dose Quetiapine and Mirtazapine for Insomnia in The Netherlands. Journal of Clinical Psychopharmacology. 2015;35(4):468-470. https://doi.org/10.1097/jcp.0000000000000338
  22. Lemoine P, Zisapel N. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opinion on Pharmacotherapy. 2012;13(6):895-905. https://doi.org/10.1517/14656566.2012.667076
  23. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews. 2005;9(1):41-50. https://doi.org/10.1016/j.smrv.2004.06.004
  24. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G. Efficacy and Safety of Exogenous Melatonin for Secondary Sleep Disorders and Sleep Disorders Accompanying Sleep Restriction: Meta-Analysis. Obstetrics & Gynecology. 2006;107(5):1162. https://doi.org/10.1097/01.aog.0000209477.99684.35
  25. Kuriyama A, Honda M, Hayashino Y. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Medicine. 2014;15(4):385-392. https://doi.org/10.1016/j.sleep.2013.11.788
  26. Laudon M, Frydman-Marom A. Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders. International Journal of Molecular Sciences. 2014;15(9):15924-15950. https://doi.org/10.3390/ijms150915924
  27. Slaughter SR, Hearns-Stokes R, van der Vlugt T, Joffe HV. FDA Approval of Doxylamine—Pyridoxine Therapy for Use in Pregnancy. New England Journal of Medicine. 2014;370(12):1081-1083. https://doi.org/10.1056/nejmp1316042
  28. Strygin KN. Sleep disorders upon acute and chronic stress: a protective role of hypnotics. Effektivnaya Farmakoterapiya. 2014;22:16-21. (In Russ.)
  29. Vande Griend JP, Anderson SL. Histamine-1 receptor antagonism for treatment of insomnia. Journal of the American Pharmacists Association. 2012;52(6):210-219. https://doi.org/10.1331/japha.2012.12051
  30. Culpepper L, Wingertzahn MA. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia. The Primary Care Companion For CNS Disorders. 2015;17(6):10.4088/PCC.15r01798. https://doi.org/10.4088/pcc.15r01798
  31. Smith GM, Smith PH. Effects of doxylamine and acetaminophen on postoperative sleep. Clinical Pharmacology & Therapeutics. 1985;37(5):549-557.
  32. Melnikov AYu, Lavrik SYu, Bikbulatova LF, Raginene IG, Ivanova YaA, Zakharov AV. Effectiveness of reslip (doxylamine) in short-term insomnia: multicenter comparative randomized study. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(4-2):56-59. (In Russ.) https://doi.org/10.17116/jnevro20171174256-59
  33. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality. Pharmacopsychiatry. 2000;33(2):47-53. https://doi.org/10.1055/s-2000-7972
  34. O’Connell B, Dowling M. Dialectical behaviour therapy (DBT) in the treatment of borderline personality disorder. Journal of Psychiatric and Mental Health Nursing. 2013;21(6):518-525. https://doi.org/10.1111/jpm.12116
  35. Linehan MM. DBT Skills Training Manual. New York: Second edition; 2015.
  36. Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia. Annals of Internal Medicine. 2015;163(3):191. https://doi.org/10.7326/m14-2841
  37. Edinger JD, Sampson WS. A Primary Care «Friendly» Cognitive Behavioral Insomnia Therapy. Sleep. 2003;26(2):177-182. https://doi.org/10.1093/sleep/26.2.177
  38. Germain A, Buysse DJ. Brief Behavioral Treatment of Insomnia. Behavioral Treatments for Sleep Disorders. 2011;15:143-150. https://doi.org/10.1016/b978-0-12-381522-4.00015-8
  39. Boullin P, Ellwood C, Ellis J. Group vs. Individual Treatment for Acute Insomnia: A Pilot Study Evaluating a «One-Shot» Treatment Strategy. Brain Sciences. 2016;7(12):1. https://doi.org/10.3390/brainsci7010001

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.